Posts

Aardvark to unblind Phase 3 ARD-101 data early after FDA clinical hold

on

FDA Fully Lifts Clinical Hold on Intellia Therapeutics' CRISPR Gene Therapy Trials for ATTR Amyloidosis

on

FDA Places Clinical Holds on Regenxbio's RGX-111 and RGX-121 Gene Therapy Trials After Brain Tumor in Patient

on

Biopharma Bites: Teva, Kinaset Funding Wins, Camzyos Teen Approval, Lynk and Lyra's Mixed Fortunes

on

Kymera’s oral “Dupixent-in-a-pill” KT-621 shows strong early eczema results

on

Imfinzi Gains FDA Approval for Early Gastric and GEJ Cancers; BiomX Nebulizer Faces FDA Scrutiny

on

WuXi AppTec Divests China Clinical Services to Hillhouse Capital, Refocuses on Manufacturing Business

on

WuXi AppTec Sells China-Based Clinical Research Units to Hillhouse Investment Management

on

WuXi AppTec Sells China-Based Clinical Research Units to Hillhouse Investment Management

on

METiS BioTech Announces China's First AI-Enabled Formulation Drug Candidate to Complete Phase III Clinical Trial

on